Binding affinity to HIV-1 HXB2 gp41 N-terminal heptad repeat assessed as thermostability of protein-compound complex at 10 uM after 30 mins by CD spectroscopic analysis
Inhibition of HIV-1 HXB2 gp41 N-terminal heptad repeat-mediated fusion between infected HL2/3 cells to target TZM-bl cells after 6 hrs by luciferase reporter gene assay
Antiviral activity against HIV1 NL4-3 pseudovirus infected in human TZM-bl cells assessed as inhibition of viral entry into cells after 48 hrs by single-cycle infection assay
Antiviral activity against wild type HIV1 NL4-3 infected in human TZM-bl cells assessed as inhibition of viral replication after 2 days by luciferase reporter gene assay
Antiviral activity against HIV-1 ZM214M.15 pseudovirus infected in human TZM-bl cells assessed as inhibition of viral entry into cells after 48 hrs by single-cycle infection assay
Antiviral activity against HIV-1 SF162 pseudovirus infected in human TZM-bl cells assessed as inhibition of viral entry into cells after 48 hrs by single-cycle infection assay
Antiviral activity against HIV-1 SC42261.8 pseudovirus infected in human TZM-bl cells assessed as inhibition of viral entry into cells after 48 hrs by single-cycle infection assay
Antiviral activity against wild type HIV1 NL4-3 infected in human TZM-bl cells assessed as inhibition of viral entry into cells after 48 hrs by single-cycle infection assay
Antiviral activity against ENF-resistant HIV1 NL4-3 harboring gp41 N-terminal heptad repeat D36G mutant infected in human TZM-bl cells assessed as inhibition of viral entry into cells after 48 hrs by single-cycle infection assay